Health innovation in developing countries to address diseases of the poor

Submitted by Vanessa Suane ([email protected]) on 2016-05-07T15:09:34Z No. of bitstreams: 1 2005. Health innovation in developing countries to address diseases of the poor.pdf: 511507 bytes, checksum: 4ed9c3e19b5b299d6bc65c66aad2ebaf (MD5)Approved for entry into archive by Vanessa Suane ([email protected]) on 2016-05-07T15:31:05Z (GMT) No. of bitstreams: 1 2005. Health innovation in developing countries to address diseases of the poor.pdf: 511507 bytes, checksum: 4ed9c3e19b5b299d6bc65c66aad2ebaf (MD5)Made available in DSpace on 2016-05-07T15:31:05Z (GMT). No. of bitstreams: 1 2005. Health innovation in developing countries to address diseases of the poor.pdf: 511507 bytes, checksum: 4ed9c3e19b5b299d6bc65c66aad2ebaf (MD5) Previous issue date: 2005Fundação Oswaldo Cruz. Centro de Desenvolvimento Tecnológico em Saúde. Rio de Janeiro, RJ, Brasil.Programme Manager. Management Sciences for Health. Ferney-Voltaire, France.Organization of Pharmaceutical Producers of India. Bombay, India.Program for Appropriate Technology in Health. Seattle, USA .Health Equity. The Rockefeller Foundation. New York, USA.Intellectual Property Management Division. Council for Scientific and Industrial Research. New Delhi, India.Mission of the United Kingdom to the United Nations. United Kingdom, UK.UCT Innovation, University of Cape Town. Cape Town, South Africa.George Washington University. Washington, D.C., USA.Global Health Programs, The Bill and Melinda Gates FoundationBoston University School of Public Health. The Bill and Melinda Gates Foundation. Seattle, USA.Provost and Dean For Global Health. Boston University School of Public Health. Boston, USA.Arizona State University. Tempe, USA / Cornell University. Ithaca, USA.FK Biotechnology. Brazil.Department of Economics. Seoul National University. Seoul, Korea.Arizona State University. Tempe, USA.Council for Scientific and Industrial Research. New Delhi, India.Biological Products Division. Korean Food and Drug Administration. Seoul, Korea.Global Forum for Health Research. Geneva, Switzerland.Science Attaché. South African Embassy. Brussels, Belgium.The Concept Foundation. Bangkok, Thailand.Special Programme for Research and Training in Tropical Diseases. World Health Organization (WHO). Geneva, Switzerland.Global Forum for Health Research. Geneva, Switzerland.Canadian Program on Genomics and Global health. University of Toronto Joint Centre for Bioethics and Departments of Public Health Sciences. Toronto, Canada.University of Toronto Joint Centre for Bioethics. Toronto, Canada / University of Toronto. Toronto, Canada / University Health Network. Toronto, Canada.Korea Institute for International Economic Policy. Seoul, Korea.There is a great unmet need for health Technologies to address diseases of the poor in developing countries. At the same time, there is a rapidly growing capabil‐ity to undertake health innovation in many develop‐ing countries (Innovative Developing Countries ‐ IDCs). IDCs have the capacity to develop, manufac‐ture, ensure safety, and market new health products and to develop, test and introduce new health poli‐cies or strategies. They are distinguished by their rap‐idly growing strength in health innovation as illus‐trated by increasing patenting and publishing activi‐ties; increasing investments in technology by both the public and private sectors; rapidly growing number of health technology companies; and health systems able to analyze, evaluate and adopt new practices and technologies. This innovation capability provides an underlev‐eraged opportunity to accelerate the development of new products, policies and strategies for diseases of the poor. We call for the formation of an Initiative for Health Product Innovation in Developing Countries. Its primary mission will be to accelerate the translation of new knowledge into health innovations relevant to the diseases of the poor and to economic growth, tak‐ing into account national priorities and sensitivities. The Initiative could promote innovation through programs to (i) support research on health innovation systems; (ii) promote collaboration and coordination among countries to develop, disseminate and imple‐ment good practices; and (iii) implemente demonstra‐tion projects. Such an Initiative would help maximize existing and growing investments by developing countries in health research, and complement global efforts to address health disparities and achieve the Millen‐nium Development Goals

Health innovation networks to help developing Countries address neglected diseases

Gross inequities in disease burden between developed and developing countries are now the subject of intense global attention. Public and private donors have marshaled resources and created organizational structures to accelerate the development of new health products and to procure and distribute drugs and vaccines for the poor. Despite these encouraging efforts directed primarily from and funded by industrialized countries, sufficiency and sustainability remain enormous challenges because of the sheer magnitude of the problem. Here we highlight a complementary and increasingly important means to improve health equity: the growing ability of some developing countries to undertake health innovation